BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 32295457)

  • 1. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
    Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
    J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
    Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
    Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotection by post-conditioning with exogenous triiodothyronine in isolated perfused rat hearts and isolated adult rat cardiomyocytes.
    Lieder HR; Braczko F; Gedik N; Stroetges M; Heusch G; Kleinbongard P
    Basic Res Cardiol; 2021 Apr; 116(1):27. PubMed ID: 33876304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxin mitigates microvascular damage and inflammation following cardiac ischemia-reperfusion.
    Gao XM; Su Y; Moore S; Han LP; Kiriazis H; Lu Q; Zhao WB; Ruze A; Fang BB; Duan MJ; Du XJ
    Basic Res Cardiol; 2019 Jun; 114(4):30. PubMed ID: 31218471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
    Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium 4-Phenylbutyrate Attenuates Myocardial Reperfusion Injury by Reducing the Unfolded Protein Response.
    Takatori O; Usui S; Okajima M; Kaneko S; Ootsuji H; Takashima SI; Kobayashi D; Murai H; Furusho H; Takamura M
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):283-292. PubMed ID: 27909014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remifentanil Induces Cardio Protection Against Ischemia/Reperfusion Injury by Inhibiting Endoplasmic Reticulum Stress Through the Maintenance of Zinc Homeostasis.
    Sheng M; Zhang G; Wang J; Yang Q; Zhao H; Cheng X; Xu Z
    Anesth Analg; 2018 Jul; 127(1):267-276. PubMed ID: 29771714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
    García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B
    Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
    Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
    J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes.
    Alloatti G; Arnoletti E; Bassino E; Penna C; Perrelli MG; Ghé C; Muccioli G
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H470-81. PubMed ID: 20525876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Extracellular Domain (p75ECD) of the Neurotrophin Receptor p75 Attenuates Myocardial Ischemia-Reperfusion Injury by Inhibiting the p-JNK/Caspase-3 Signaling Pathway in Rat Microvascular Pericytes.
    Fang J; Wei Z; Zheng D; Ying T; Hong H; Hu D; Lin Y; Jiang X; Wu L; Lan T; Yang Z; Zhou X; Chen L
    J Am Heart Assoc; 2020 Jul; 9(13):e016047. PubMed ID: 32567476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a pharmacological inhibitor of Epac1 that protects the heart against acute and chronic models of cardiac stress.
    Laudette M; Coluccia A; Sainte-Marie Y; Solari A; Fazal L; Sicard P; Silvestri R; Mialet-Perez J; Pons S; Ghaleh B; Blondeau JP; Lezoualc'h F
    Cardiovasc Res; 2019 Oct; 115(12):1766-1777. PubMed ID: 30873562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
    Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin Receptor Agonist Ramelteon Reduces Ischemia-Reperfusion Injury Through Activation of Mitochondrial Potassium Channels.
    Stroethoff M; Christoph I; Behmenburg F; Raupach A; Bunte S; Senpolat S; Heinen A; Hollmann MW; Mathes A; Huhn R
    J Cardiovasc Pharmacol; 2018 Aug; 72(2):106-111. PubMed ID: 29787401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of EphrinA2 receptors in postconditioning induced cardioprotection in rats.
    Kaur K; Singh N; Dhawan RK
    Eur J Pharmacol; 2020 Sep; 883():173231. PubMed ID: 32589885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress.
    Li J; Zhao Y; Zhou N; Li L; Li K
    J Diabetes Res; 2019; 2019():7869318. PubMed ID: 31886285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shining the spotlight on cardioprotection: beyond the cardiomyocyte.
    Davidson SM; Andreadou I; Garcia-Dorado D; Hausenloy DJ
    Cardiovasc Res; 2019 Jun; 115(7):1115-1116. PubMed ID: 30865272
    [No Abstract]   [Full Text] [Related]  

  • 18. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
    Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
    Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grb2-associated binder 1 is essential for cardioprotection against ischemia/reperfusion injury.
    Sun L; Chen C; Jiang B; Li Y; Deng Q; Sun M; An X; Yang X; Yang Y; Zhang R; Lu Y; Zhu DS; Huo Y; Feng GS; Zhang Y; Luo J
    Basic Res Cardiol; 2014 Jul; 109(4):420. PubMed ID: 24951957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous angiotensin-(1-7)/Mas receptor/NO pathway mediates the cardioprotective effects of pacing postconditioning.
    Abwainy A; Babiker F; Akhtar S; Benter IF
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H104-12. PubMed ID: 26519026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.